The Patent Finder

ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use

Genentech, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 61/054,709, filed May 20, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,691,531ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use
In force
 · Medium confidence
Genentech, Inc.In force
Medium confidence
US 9,896,506ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use
In force
 · Low confidence
Genentech, Inc.In force
Low confidence
US 10,494,432ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use
In force
 · Medium confidence
Genentech, Inc.In force
Medium confidence
US 10,544,218ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use
In force
 · Medium confidence
Genentech, Inc.In force
Medium confidence
US RE48,558ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use
In force (reinstated)
 · Low confidence
Genentech, Inc.In force (reinstated)
Low confidence
US 8,722,857ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use
In force
 · High confidence
Genentech, Inc.In force
High confidence
US 8,088,378ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use
In force
 · High confidence
Genentech, Inc.In force
High confidence
US 8,545,850ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use
Surrendered on reissue May 18, 2021
Surrendered on reissue May 18, 2021 · Low confidence
Genentech, Inc.Surrendered on reissue May 18, 2021Surrendered on reissue May 18, 2021
Low confidence
Application 14/219,473ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use
Abandoned
Abandoned Nov 14, 2016
Genentech, Inc.AbandonedAbandoned Nov 14, 2016
Application 16/600,331ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use
Abandoned
Abandoned Sep 7, 2022
Genentech, Inc.AbandonedAbandoned Sep 7, 2022
4 more patents in this group · Pro
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14, including 1 expired.
Upgrade to Pro
7 of these are in force and held by Genentech, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited